Percutaneous mitral valve repair with MitraClip is not superior to medical therapy alone in patients with secondary mitral regurgitation. At ESC18, we discussed the results of MITRA-FR with Jean-Francois Obadia (Chirurgie Cardio-Vasculaire et Transplantation Cardiaque Hopital Louis Pradel, Lyon), Principal Investigator of the study.
MITRA-FR: MitraClip vs medical therapy
Dai congressiIntervisteCARDIOINFO@ESC2018
Scelti dall'editore
- TRANSITION vs PARADIGM-HF vs TITRATION
Michele Senni Dipartimento Cardiovascolare ASST Papa Giovanni XXIII, Bergamo
- Doppia vs singola arteria mammaria: stiamo perdendo un’altra certezza?
Non c’è differenza nella sopravvivenza né negli eventi avversi a 5 anni e rischio di…